收稿日期: 2022-09-15
网络出版日期: 2023-01-02
血尿酸/高密度脂蛋白胆固醇比值(serum uric acid to high-density lipoprotein cholesterol ratio, UHR)作为一项能反映炎症水平和代谢状态的新型标志物,已被证实与2型糖尿病、代谢综合征、非酒精性脂肪性肝病、缺血性心肌病等糖脂代谢相关疾病及其他疾病有着不同程度的相关性,因此,本文主要阐述UHR在糖脂代谢相关疾病中的预测、诊断、评估病情控制情况的作用。
关键词: 血尿酸/高密度脂蛋白胆固醇比值; 代谢性疾病; 2型糖尿病
张雪晴 , 陈树春 . 血尿酸与高密度脂蛋白胆固醇比值在糖脂代谢相关疾病中的研究进展[J]. 临床荟萃, 2022 , 37(11) : 1044 -1047 . DOI: 10.3969/j.issn.1004-583X.2022.11.015
[1] | Baker RG, Hayden MS, Ghosh S. NF-κB, inflammation, and metabolic disease[J]. Cell Metab, 2011, 13(1):11-22. |
[2] | Lee YS, Olefsky J. Chronic tissue inflammation and metabolic disease[J]. Genes Dev, 2021, 35(5-6): 307-328. |
[3] | Kosekli MA, Kurtkulagii O, Kahveci G, et al. The association between serum uric acid to high density lipoprotein-cholesterol ratio and non-alcoholic fatty liver disease: The abund study[J]. Rev Assoc Med Bras, 2021, 67(4): 549-554. |
[4] | Cao W, Zheng RD, Xu SH, et al. Association between sex hormone and blood uric acid in male patients with type 2 diabetes[J]. Int J Endocrinol, 2017, 2017: 4375253. |
[5] | 中华医学会内分泌学分会. 中国高尿酸血症与痛风诊疗指南(2019)[J]. 中华内分泌代谢杂志, 2020, 36(1): 1-13. |
[6] | George J, Struthers AD. Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress[J]. Vasc Health Risk Man, 2009, 5(1): 265-272. |
[7] | Borghi C, Agnoletti D, Cicero AFG, et al. Uric acid and hypertension: A review of evidence and future perspectives for the management of cardiovascular risk[J]. Hypertension, 2022, 79(9): 1927-1936. |
[8] | Copur S, Demiray A, Kanbay M. Uric acid in metabolic syndrome: Does uric acid have a definitive role?[J]. Eur J Intern Med, 2022, 103(9): 4-12. |
[9] | Hwang J, Lee MY, Ahn JK, et al. Relationship between changing body mass index and serum uric acid alteration among clinically apparently healthy Korean men[J]. Arthrit Care Res, 2022, 74(8): 1277-1286. |
[10] | Yan P, Zhang Z, Wan Q, et al. Association of serum uric acid with bone mineral density and clinical fractures in Chinese type 2 diabetes mellitus patients: A cross-sectional study[J]. Clin Chim Acta, 2018, 486(11): 76-85. |
[11] | Yang S, Ye Z, Liu M, et al. Association of serum uric acid with all-cause and cardiovascular mortality among adults with nonalcoholic fatty liver disease[J]. Clin Endocrinol, 2022, 98(1): 49-58. |
[12] | Van der vorst EPC. High-density lipoproteins and apolipoprotein A1[J]. Subcell Biochem, 2020, 94: 399-420. |
[13] | Aktas G, Kocak MZ, Bilgin S, et al. Uric acid to HDL cholesterol ratio is a strong predictor of diabetic control in men with type 2 diabetes mellitus[J]. Aging Male, 2020, 23(5): 1098-1102. |
[14] | Nathan DM, Zinman B, Cleary PA, et al. Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: The diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005)[J]. Arch Intern Med, 2009, 169(14): 1307-1316. |
[15] | Kowalski AJ, Dutta S. It's time to move from the A1c to better metrics for diabetes control[J]. Diabetes Technol Ther, 2013, 15(3): 194-196. |
[16] | 尤玉青, 李伟, 周东浩. 血尿酸/高密度脂蛋白胆固醇比值与糖尿病肾脏疾病的相关性研究[J]. 中国糖尿病杂志, 2021, 29(10): 749-753. |
[17] | Cheung N, Mitchell P, Wong TY. Diabetic retinopathy[J]. Lancet, 2010, 376(9735): 124-136. |
[18] | Cipriani C, Colangelo L, Santori R, et al. The interplay between bone and glucose metabolism[J]. Front Endocrinol (Lausanne), 2020, 11(24): 122. |
[19] | Dhawan S, Natarajan R. Epigenetics and type 2 diabetes risk[J]. Curr Diabetes Rep, 2019, 19(8): 47. |
[20] | Zhang Q, Zhou J, Wang Q, et al. Association between bone mineral density and lipid profile in Chinese women[J]. Clin Interv Aging, 2020, 15(15):1649-1664. |
[21] | Niu P, Li H, Liu D, et al. Association between HDL-C and bone mineral density: An cross-sectional analysis[J]. Int J Gen Med, 2021, 14(26): 8863-8872. |
[22] | Tang Y, Wang S, Yi Q, et al. High-density lipoprotein cholesterol is negatively correlated with bone mineral density and has potential predictive value for bone loss[J]. Lipids Health Dis, 2021, 20(1): 75. |
[23] | 相爱霞, 宋勇刚, 于婷婷, 等. 2型糖尿病血清尿酸与高密度脂蛋白比值和骨代谢、骨密度和骨质疏松的相关研究[J]. 糖尿病新世界, 2022, 25(12): 26-30. |
[24] | Chen YY, Kao TW, Yang HF, et al. The association of uric acid with the risk of metabolic syndrome, arterial hypertension or diabetes in young subjects- An observational study[J]. Clin Chim Acta, 2018, 478: 68-73. |
[25] | Kocak MZ, Aktas G, Erkus E, et al. Serum uric acid to HDL-cholesterol ratio is a strong predictor of metabolic syndrome in type 2 diabetes mellitus[J]. Rev Assoc Med Bras(1992), 2019, 65(1): 9-15. |
[26] | Yazdi F, Baghaei MH, Baniasad A, et al. Investigating the relationship between serum uric acid to high-density lipoprotein ratio and metabolic syndrome[J]. Endocrinol Diabetes Metab, 2022, 5(1): e00311. |
[27] | 中华医学会肝病学分会脂肪肝和酒精性肝病学组, 中国医师协会脂肪性肝病专家委员会. 非酒精性脂肪性肝病防治指南(2018年更新版)[J]. 实用肝脏病杂志, 2018, 21(2): 177-186. |
[28] | Hijona E, Hijona L, Arenas JI, et al. Inflammatory mediators of hepatic steatosis[J]. Mediat Inflamm, 2010, 2010: 837419. |
[29] | Zhang YN, Wang QQ, Chen YS, et al. Association between serum uric acid to HDL-cholesterol ratio and nonalcoholic fatty liver disease in lean Chinese adults[J]. Int J Endocrinol, 2020, 2020: 5953461. |
[30] | Sagris M, Antonopoulos AS, Theofilis P, et al. Risk factors profile of young and older patients with myocardial infarction[J]. Cardiovasc Res, 2022, 118(10): 2281-2292. |
[31] | Park B, Jung DH, Lee YJ. Predictive value of serum uric acid to HDL cholesterol ratio for incident ischemic heart disease in non-diabetic Koreans[J]. Biomedicines, 2022, 10(6): 1422. |
[32] | Antonelli A, Ferrari SM, Corrado A, et al. Autoimmune thyroid disorders[J]. Autoimmun Rev, 2015, 14(2): 174-180. |
[33] | Volpé R. The pathology of thyroiditis[J]. Hum Pathol, 1978, 9(4): 429-438. |
[34] | Vukovic R, Zeljkovic A, Bufan B, et al. Hashimoto thyroiditis and dyslipidemia in childhood: A review[J]. Front Endocrinol (Lausanne), 2019, 10(10): 868. |
[35] | Kurtkulagi O, Tel BMA, Kahveci G, et al. Hashimoto's thyroiditis is associated with elevated serum uric acid to high density lipoprotein-cholesterol ratio[J]. Rom J Intern Med, 2021, 59(4): 403-408. |
[36] | Aktas G, Khalid A, Kurtkulagi O, et al. Poorly controlled hypertension is associated with elevated serum uric acid to HDL-cholesterol ratio: A cross-sectional cohort study[J]. Postgrad Med, 2022, 134(3): 297-302. |
/
〈 |
|
〉 |